Caplan Jay David
- SEC CIK
- 0001419217
No open-market purchases or sales filed in the past year.
Current role at each company
- GUTS Fractyl Health, Inc.President, Chief Product Off.as of Dec 17, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Caplan Jay David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 (view filing) | Jan 30-31 | 4 days | Caplan Jay DavidPresident, Chief Product Off. | SSale | −43.8K | $1.88 | −$82.3K | −22.2%153.5K after | 2 lots10b5-1 |
| Nov 13, 2024 (view filing) | Nov 11 | 2 days | Caplan Jay DavidPresident, Chief Product Off. | SSale | −64.2K | $2.47 | −$158.6K | −29.5%153.5K after | |
| Sep 13, 2024 (view filing) | Sep 12 | 1 day | Caplan Jay DavidPresident, Chief Product Off. | SSale | −65.0K | $2.90 | −$188.5K | −68.1%30.5K after |